Sakr WA - Search Results

1

The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients.

Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD. Sakr WA, et al. J Urol. 1993 Aug;150(2 Pt 1):379-85. doi: 10.1016/s0022-5347(17)35487-3. J Urol. 1993. PMID: 8326560

2

Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.

Lieberman R, Nelson WG, Sakr WA, Meyskens FL Jr, Klein EA, Wilding G, Partin AW, Lee JJ, Lippman SM. Lieberman R, et al. Among authors: sakr wa. Urology. 2001 Apr;57(4 Suppl 1):4-27. doi: 10.1016/s0090-4295(00)00931-6. Urology. 2001. PMID: 11295590

3

Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia.

Sakr WA, Partin AW. Sakr WA, et al. Urology. 2001 Apr;57(4 Suppl 1):115-20. doi: 10.1016/s0090-4295(00)00953-5. Urology. 2001. PMID: 11295607 Review.

4

Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111.

Hussain M, Tangen CM, Lara PN Jr, Vaishampayan UN, Petrylak DP, Colevas AD, Sakr WA, Crawford ED; Southwest Oncology Group. Hussain M, et al. Among authors: sakr wa. J Clin Oncol. 2005 Dec 1;23(34):8724-9. doi: 10.1200/JCO.2005.02.4448. J Clin Oncol. 2005. PMID: 16314632 Clinical Trial.

5

CYP3A4 genetic variant and disease-free survival among white and black men after radical prostatectomy.

Powell IJ, Zhou J, Sun Y, Sakr WA, Patel NP, Heilbrun LK, Everson RB. Powell IJ, et al. Among authors: sakr wa. J Urol. 2004 Nov;172(5 Pt 1):1848-52. doi: 10.1097/01.ju.0000142779.76603.be. J Urol. 2004. PMID: 15540736

6

Potential pathologic markers for prostate chemoprevention studies.

Sakr WA, Lucia MS. Sakr WA, et al. Urol Clin North Am. 2004 May;31(2):227-35. doi: 10.1016/j.ucl.2004.03.001. Urol Clin North Am. 2004. PMID: 15123403 Review.

7

Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy.

Bianco FJ Jr, Justa D, Grignon DJ, Sakr WA, Pontes JE, Wood DP Jr. Bianco FJ Jr, et al. Among authors: sakr wa. Urol Oncol. 2004 Jul-Aug;22(4):290-4. doi: 10.1016/S1078-1439(03)00144-3. Urol Oncol. 2004. PMID: 15283885

8

Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate Cancer.

Heath EI, Heilbrun LK, Smith D, Schopperle WM, Ju Y, Bolton S, Ahmed Q, Sakr WA. Heath EI, et al. Among authors: sakr wa. Anticancer Res. 2018 Nov;38(11):6361-6366. doi: 10.21873/anticanres.12994. Anticancer Res. 2018. PMID: 30396958 Free PMC article.

9

Vitamin D receptor gene polymorphisms and disease free survival after radical prostatectomy.

Williams H, Powell IJ, Land SJ, Sakr WA, Hughes MR, Patel NP, Heilbrun LK, Everson RB. Williams H, et al. Among authors: sakr wa. Prostate. 2004 Nov 1;61(3):267-75. doi: 10.1002/pros.20103. Prostate. 2004. PMID: 15368470

10

Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.

Bianco FJ Jr, Wood DP Jr, Grignon DJ, Sakr WA, Pontes JE, Powell IJ. Bianco FJ Jr, et al. Among authors: sakr wa. J Urol. 2002 Aug;168(2):479-82. J Urol. 2002. PMID: 12131292

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results